Fktn-deficient dystroglycanopathy mice develop moderate to severe muscular dystrophy with skeletal muscle developmental and/or regeneration defects. This evidence concerns the gene FKTN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.